VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
WFPRX
Price
$53.16
Change
-$0.26 (-0.49%)
Updated
Sep 20 closing price
Ad is loading...

VMVAX vs WFPRX

Header iconVMVAX vs WFPRX Comparison
Open Charts VMVAX vs WFPRXBanner chart's image
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
Allspring Special Mid Cap Value R6
Price$53.16
Change-$0.26 (-0.49%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VMVAX vs WFPRX Comparison Chart
Loading...
VS
VMVAX vs. WFPRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMVAX is a StrongBuy and WFPRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. WFPRX (14.2B). VMVAX pays higher dividends than WFPRX: VMVAX (2.14) vs WFPRX (1.21). VMVAX was incepted earlier than WFPRX: VMVAX (13 years) vs WFPRX (11 years). WFPRX is a more actively managed with annual turnover of: 27.00 vs. VMVAX (22.00). WFPRX has a lower initial minimum investment than VMVAX: WFPRX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. WFPRX (20.21). VMVAX return over 5 years is better than : 48.82 vs. WFPRX (34.74).
VMVAXWFPRXVMVAX / WFPRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years11 years-
Gain YTD14.94616.10593%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.5B14.2B215%
Annual Yield % from dividends2.141.21177%
Returns for 1 year25.3520.21125%
Returns for 3 years20.718.83235%
Returns for 5 years48.8234.74141%
Returns for 10 years100.8867.13150%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio